(Español) La FDA aprueba el primer autoinyector de clorhidrato de nalmefeno para revertir la sobredosis de opioides News provided by: August 14, 2024 SHARE THIS ARTICLE Tell a friendClose Your NameFriend Email Enter Message To Friend Sorry, this entry is only available in European Spanish.
